Tff Pharmaceuticals Stock In The News

TFFP Stock  USD 0.30  0.02  6.25%   
Our overall analysis of Tff Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Tff Pharmaceuticals. The specific impact of Tff Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Tff Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Tff Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Tff Pharmaceuticals Backtesting and Tff Pharmaceuticals Hype Analysis.
To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.

Tff Pharmaceuticals Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
https://www.globenewswire.com/news-release/2023/11/30/2788519/0/en/TFF-Pharmaceuticals-Appoints-Catherine-Lee-J-D-to-Board-of-Directors.html
 Bullish
Macroaxis News: globenewswire.com
TFF Pharmaceuticals Appoints Michael Patane, Ph.D., to Board of Directors
https://www.globenewswire.com/news-release/2023/11/30/2788551/0/en/TFF-Pharmaceuticals-Appoints-Michael-Patane-Ph-D-to-Board-of-Directors.html
 Bullish
Macroaxis News: globenewswire.com
TFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023
https://www.globenewswire.com/news-release/2023/11/27/2786020/0/en/TFF-Pharmaceuticals-to-Participate-in-the-2023-Benchmark-Discovery-One-on-One-Investor-Conference-December-7-2023.html
 Neutral
Macroaxis News: globenewswire.com
TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2023/11/14/2780502/0/en/TFF-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
TFF Pharmaceuticals Announces Publicatio...
https://www.globenewswire.com/news-release/2023/11/08/2776700/0/en/TFF-Pharmaceuticals-Announces-Publication-of-Data-Demonstrating-Feasibility-of-Intranasal-Delivery-of-Monoclonal-Antibodies-with-Thin-Film-Freezing.html
 Neutral
Macroaxis News: globenewswire.com
TFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023
https://www.globenewswire.com/news-release/2023/11/07/2775579/0/en/TFF-Pharmaceuticals-to-Hold-Third-Quarter-2023-Financial-and-Business-Results-Conference-Call-on-November-14-2023.html
 Bullish
Macroaxis News: globenewswire.com
TFF Pharmaceuticals Congratulates our Sc...
https://www.globenewswire.com/news-release/2023/10/02/2753198/0/en/TFF-Pharmaceuticals-Congratulates-our-Scientific-Advisory-Board-Member-Drew-Weissman-M-D-Ph-D-for-Receiving-the-Nobel-Prize-in-Physiology-or-Medicine-for-his-Pioneering-Work-Enabli.html
 Bullish
Macroaxis News: globenewswire.com
TFF Pharmaceuticals to Participate in Upcoming Investor Conferences
https://www.globenewswire.com/news-release/2023/09/28/2751653/0/en/TFF-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html
 Bullish
Macroaxis News: globenewswire.com
TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023
https://www.globenewswire.com/news-release/2023/08/23/2730276/0/en/TFF-Pharmaceuticals-to-Participate-in-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference-September-11-13-2023.html
 Bullish
Macroaxis News: globenewswire.com
TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
https://www.globenewswire.com/news-release/2023/08/17/2727642/0/en/TFF-Pharmaceuticals-Announces-Closing-of-5-7-Million-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Over-Allotment-Option.html
 Bullish

Tff Pharmaceuticals Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Tff and other traded companies coverage with news coverage. We help investors stay connected with Tff headlines for the 27th of November to make an informed investment decision based on correlating the impacts of news items on Tff Stock performance. Please note that trading solely based on the Tff Pharmaceuticals hype is not for everyone as timely availability and quick action are needed to avoid losses.
Tff Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Tff Pharmaceuticals investors visualize upcoming and past events in order to time the market based on Tff Pharmaceuticals noise-free hype analysis.
Tff Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Tff earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Tff Pharmaceuticals that are available to investors today. That information is available publicly through Tff media outlets and privately through word of mouth or via Tff internal channels. However, regardless of the origin, that massive amount of Tff data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tff Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tff Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tff Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tff Pharmaceuticals alpha.

Tff Largest EPS Surprises

Earnings surprises can significantly impact Tff Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-14
2023-09-30-0.11-0.090.0218 
2021-03-10
2020-12-31-0.23-0.26-0.0313 
2023-05-11
2023-03-31-0.23-0.190.0417 
2022-11-14
2022-09-30-0.33-0.290.0412 
2020-05-14
2020-03-31-0.24-0.20.0416 
2023-08-15
2023-06-30-0.19-0.140.0526 
View All Earnings Estimates

Tff Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Tff Pharmaceuticals Stock. Current markets are strongly bearish. About 75% of major world exchanges and indexes are down. See today's market update for more information.
Google News at Macroaxis
20th of November 2024
TFF Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
at news.google.com 
Gurufocus Stories at Macroaxis
15th of November 2024
ARMISTICE CAPITAL, LLC Acquires Shares in TFF Pharmaceuticals Inc
at gurufocus.com 
Macroaxis News
15th of October 2024
Acquisition by Rocamboli Stephen of 3165 shares of Tff Pharmaceuticals subject to Rule 16b...
at MacroaxisInsider 
seekingalpha News
11th of September 2024
TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment
at seekingalpha.com 
Yahoo News
3rd of September 2024
TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Confer...
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tff Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tff Pharmaceuticals' short interest history, or implied volatility extrapolated from Tff Pharmaceuticals options trading.

Additional Tools for Tff Stock Analysis

When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.